+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Radioimmunoassays Market - Global Forecast 2026-2032- Product Image
Radioimmunoassays Market - Global Forecast 2026-2032- Product Image
New

Radioimmunoassays Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 184 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6012225
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The radioimmunoassays market is undergoing substantial change, driven by intersecting dynamics in technology, regulation, and global supply structures. Senior leaders evaluating procurement strategies and laboratory investments must reevaluate their priorities to safeguard continuity and capitalize on reliable assay sensitivity.

Market Snapshot

The Radioimmunoassays Market grew from USD 490.78 million in 2025 to USD 520.05 million in 2026. It is expected to continue growing at a CAGR of 4.66%, reaching USD 675.38 million by 2032. This sustained growth reflects enduring demand across clinical diagnostics, pharmaceutical research, and emerging areas where high sensitivity and proven assay platforms remain preferred.

Scope & Segmentation

  • Product Formats: Kits for multiplex and single-analyte detection, plus reagents including monoclonal and polyclonal antibodies, and radiolabeled tracers.
  • Application Domains: Clinical diagnostics in cardiology, endocrinology, oncology; research applications in pharmaceutical and academic settings.
  • End-User Profiles: Hospital laboratories, independent diagnostic labs, public and private hospitals, academic and pharmaceutical research institutes.
  • Isotopes: Primarily iodine-125 for lower-energy applications and iodine-131 for specialized needs, each influencing logistics and regulatory planning.
  • Regional Coverage: Americas, Europe Middle East and Africa (EMEA), Asia-Pacific—each with unique market adoption, regulatory, and supply trends.
  • Technology Advances: Laboratory automation, digital workflow integration, advanced monoclonal antibody production, and documentation systems.

Key Takeaways

  • Radioimmunoassays maintain their role through a balance of high assay sensitivity and historical clinical validation for trace-level detection needs.
  • Innovations in assay design and automation are reducing manual workload and exposure risks, expanding safe usage across diverse laboratory environments.
  • Procurement and R&D leaders increasingly prioritize suppliers with validated monoclonal antibody offerings, high-quality reagent pipelines, and advanced kit traceability.
  • Segmentation by end user, application, and isotope guides organizations in allocating R&D and procurement resources for maximum operational resilience.
  • Regional market nuances, especially in regulatory maturity and local manufacturing capabilities, significantly impact adoption patterns and distribution decisions.
  • Collaboration between supply chain, regulatory, and scientific groups has become critical for continuity and timely deployment of validated kits and reagents.

Tariff Impact

Recent tariff changes and trade policy uncertainty have elevated risk within the radioimmunoassays supply chain, particularly affecting the import and logistics of radiolabeled isotopes and antibodies. Procurement teams have responded by pursuing diversified sourcing, buffer inventories, and regionally distributed supply hubs to ensure uninterrupted laboratory operations and compliance with global trade requirements.

Methodology & Data Sources

This market analysis used a multi-method research approach combining structured interviews with laboratory, procurement, and regulatory stakeholders, alongside laboratory validation of kit and reagent usability. Secondary sources included targeted reviews of scientific literature, guidelines, and regulatory documents, complemented by mapping of isotope supply and logistics networks. Data triangulation ensured robust and actionable recommendations.

Why This Report Matters

  • Enables decision-makers to benchmark supplier capabilities and optimize resource deployment across high-value assay segments.
  • Supports strategic risk mitigation, especially regarding tariff measures and sourcing disruptions affecting key technology inputs.
  • Facilitates long-term planning by connecting advances in product design, automation, and regulatory compliance to market adoption trends.

Conclusion

Strategic alignment of technology adoption, supply chain resilience, and compliance will define sustainable leadership in radioimmunoassays. Organizations that adapt workflows, partnerships, and validation approaches to evolving market realities will secure both operational continuity and market position.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Radioimmunoassays Market, by Product
8.1. Kits
8.1.1. Multiplex
8.1.2. Single Analyte
8.2. Reagents
8.2.1. Antibody
8.2.1.1. Monoclonal
8.2.1.2. Polyclonal
8.2.2. Antigen
9. Radioimmunoassays Market, by Isotope
9.1. Iodine-125
9.2. Iodine-131
10. Radioimmunoassays Market, by Application
10.1. Clinical Diagnostics
10.1.1. Cardiology
10.1.2. Endocrinology
10.1.3. Oncology
10.2. Research
10.2.1. Academic Research
10.2.2. Pharmaceutical Research
11. Radioimmunoassays Market, by End User
11.1. Diagnostic Laboratories
11.1.1. Hospital Laboratories
11.1.2. Independent Laboratories
11.2. Hospitals
11.2.1. Private Hospitals
11.2.2. Public Hospitals
11.3. Research Institutes
11.3.1. Academic Institutions
11.3.2. Pharmaceutical Companies
12. Radioimmunoassays Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Radioimmunoassays Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Radioimmunoassays Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Radioimmunoassays Market
16. China Radioimmunoassays Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Abbott Laboratories
17.6. Abcam plc
17.7. ALPCO Diagnostics, Inc.
17.8. Beckman Coulter, Inc.
17.9. Bio-Rad Laboratories, Inc.
17.10. BioCheck, Inc.
17.11. bioMérieux SA
17.12. Cisbio Bioassays SAS
17.13. Demeditec Diagnostics GmbH
17.14. DiaSorin S.p.A.
17.15. Euroimmun Medizinische Labordiagnostika AG
17.16. Fujirebio Holdings, Inc.
17.17. Institute of Isotopes Co., Ltd.
17.18. Medipan GmbH
17.19. MilliporeSigma
17.20. NovoLytiX GmbH
17.21. PerkinElmer, Inc.
17.22. Randox Laboratories Ltd.
17.23. Roche Diagnostics International AG
17.24. Siemens Healthineers AG
17.25. Thermo Fisher Scientific Inc.
17.26. Tosoh Bioscience, Inc.
List of Figures
FIGURE 1. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL RADIOIMMUNOASSAYS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL RADIOIMMUNOASSAYS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY ISOTOPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES RADIOIMMUNOASSAYS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA RADIOIMMUNOASSAYS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY MULTIPLEX, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY MULTIPLEX, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY MULTIPLEX, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY SINGLE ANALYTE, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY SINGLE ANALYTE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY SINGLE ANALYTE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY REAGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY ANTIBODY, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY ANTIBODY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY ANTIBODY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY ANTIBODY, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY MONOCLONAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY MONOCLONAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY MONOCLONAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY POLYCLONAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY POLYCLONAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY POLYCLONAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY ANTIGEN, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY ANTIGEN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY ANTIGEN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY ISOTOPE, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY IODINE-125, BY REGION, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY IODINE-125, BY GROUP, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY IODINE-125, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY IODINE-131, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY IODINE-131, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY IODINE-131, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY ENDOCRINOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY ENDOCRINOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY ENDOCRINOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY RESEARCH, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY ACADEMIC RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY ACADEMIC RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY PHARMACEUTICAL RESEARCH, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY PHARMACEUTICAL RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY PHARMACEUTICAL RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY HOSPITAL LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY HOSPITAL LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY HOSPITAL LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY INDEPENDENT LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY INDEPENDENT LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY INDEPENDENT LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 93. AMERICAS RADIOIMMUNOASSAYS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 94. AMERICAS RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 95. AMERICAS RADIOIMMUNOASSAYS MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 96. AMERICAS RADIOIMMUNOASSAYS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 97. AMERICAS RADIOIMMUNOASSAYS MARKET SIZE, BY ANTIBODY, 2018-2032 (USD MILLION)
TABLE 98. AMERICAS RADIOIMMUNOASSAYS MARKET SIZE, BY ISOTOPE, 2018-2032 (USD MILLION)
TABLE 99. AMERICAS RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 100. AMERICAS RADIOIMMUNOASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 101. AMERICAS RADIOIMMUNOASSAYS MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 102. AMERICAS RADIOIMMUNOASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 103. AMERICAS RADIOIMMUNOASSAYS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 104. AMERICAS RADIOIMMUNOASSAYS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 105. AMERICAS RADIOIMMUNOASSAYS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 106. NORTH AMERICA RADIOIMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 107. NORTH AMERICA RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 108. NORTH AMERICA RADIOIMMUNOASSAYS MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 109. NORTH AMERICA RADIOIMMUNOASSAYS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 110. NORTH AMERICA RADIOIMMUNOASSAYS MARKET SIZE, BY ANTIBODY, 2018-2032 (USD MILLION)
TABLE 111. NORTH AMERICA RADIOIMMUNOASSAYS MARKET SIZE, BY ISOTOPE, 2018-2032 (USD MILLION)
TABLE 112. NORTH AMERICA RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 113. NORTH AMERICA RADIOIMMUNOASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 114. NORTH AMERICA RADIOIMMUNOASSAYS MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 115. NORTH AMERICA RADIOIMMUNOASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 116. NORTH AMERICA RADIOIMMUNOASSAYS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 117. NORTH AMERICA RADIOIMMUNOASSAYS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 118. NORTH AMERICA RADIOIMMUNOASSAYS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 119. LATIN AMERICA RADIOIMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 120. LATIN AMERICA RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 121. LATIN AMERICA RADIOIMMUNOASSAYS MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 122. LATIN AMERICA RADIOIMMUNOASSAYS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 123. LATIN AMERICA RADIOIMMUNOASSAYS MARKET SIZE, BY ANTIBODY, 2018-2032 (USD MILLION)
TABLE 124. LATIN AMERICA RADIOIMMUNOASSAYS MARKET SIZE, BY ISOTOPE, 2018-2032 (USD MILLION)
TABLE 125. LATIN AMERICA RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 126. LATIN AMERICA RADIOIMMUNOASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 127. LATIN AMERICA RADIOIMMUNOASSAYS MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 128. LATIN AMERICA RADIOIMMUNOASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 129. LATIN AMERICA RADIOIMMUNOASSAYS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 130. LATIN AMERICA RADIOIMMUNOASSAYS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 131. LATIN AMERICA RADIOIMMUNOASSAYS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY ANTIBODY, 2018-2032 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY ISOTOPE, 2018-2032 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 145. EUROPE RADIOIMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 146. EUROPE RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 147. EUROPE RADIOIMMUNOASSAYS MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 148. EUROPE RADIOIMMUNOASSAYS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 149. EUROPE RADIOIMMUNOASSAYS MARKET SIZE, BY ANTIBODY, 2018-2032 (USD MILLION)
TABLE 150. EUROPE RADIOIMMUNOASSAYS MARKET SIZE, BY ISOTOPE, 2018-2032 (USD MILLION)
TABLE 151. EUROPE RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 152. EUROPE RADIOIMMUNOASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 153. EUROPE RADIOIMMUNOASSAYS MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 154. EUROPE RADIOIMMUNOASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 155. EUROPE RADIOIMMUNOASSAYS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 156. EUROPE RADIOIMMUNOASSAYS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 157. EUROPE RADIOIMMUNOASSAYS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 158. MIDDLE EAST RADIOIMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 159. MIDDLE EAST RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 160. MIDDLE EAST RADIOIMMUNOASSAYS MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 161. MIDDLE EAST RADIOIMMUNOASSAYS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 162. MIDDLE EAST RADIOIMMUNOASSAYS MARKET SIZE, BY ANTIBODY, 2018-2032 (USD MILLION)
TABLE 163. MIDDLE EAST RADIOIMMUNOASSAYS MARKET SIZE, BY ISOTOPE, 2018-2032 (USD MILLION)
TABLE 164. MIDDLE EAST RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 165. MIDDLE EAST RADIOIMMUNOASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 166. MIDDLE EAST RADIOIMMUNOASSAYS MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 167. MIDDLE EAST RADIOIMMUNOASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 168. MIDDLE EAST RADIOIMMUNOASSAYS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 169. MIDDLE EAST RADIOIMMUNOASSAYS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 170. MIDDLE EAST RADIOIMMUNOASSAYS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 171. AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 172. AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 173. AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 174. AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 175. AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY ANTIBODY, 2018-2032 (USD MILLION)
TABLE 176. AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY ISOTOPE, 2018-2032 (USD MILLION)
TABLE 177. AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 178. AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 179. AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 180. AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 181. AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 182. AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 183. AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 184. ASIA-PACIFIC RADIOIMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 185. ASIA-PACIFIC RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 186. ASIA-PACIFIC RADIOIMMUNOASSAYS MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 187. ASIA-PACIFIC RADIOIMMUNOASSAYS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 188. ASIA-PACIFIC RADIOIMMUNOASSAYS MARKET SIZE, BY ANTIBODY, 2018-2032 (USD MILLION)
TABLE 189. ASIA-PACIFIC RADIOIMMUNOASSAYS MARKET SIZE, BY ISOTOPE, 2018-2032 (USD MILLION)
TABLE 190. ASIA-PACIFIC RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 191. ASIA-PACIFIC RADIOIMMUNOASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 192. ASIA-PACIFIC RADIOIMMUNOASSAYS MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 193. ASIA-PACIFIC RADIOIMMUNOASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 194. ASIA-PACIFIC RADIOIMMUNOASSAYS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 195. ASIA-PACIFIC RADIOIMMUNOASSAYS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 196. ASIA-PACIFIC RADIOIMMUNOASSAYS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 197. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 198. ASEAN RADIOIMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 199. ASEAN RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 200. ASEAN RADIOIMMUNOASSAYS MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 201. ASEAN RADIOIMMUNOASSAYS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 202. ASEAN RADIOIMMUNOASSAYS MARKET SIZE, BY ANTIBODY, 2018-2032 (USD MILLION)
TABLE 203. ASEAN RADIOIMMUNOASSAYS MARKET SIZE, BY ISOTOPE, 2018-2032 (USD MILLION)
TABLE 204. ASEAN RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 205. ASEAN RADIOIMMUNOASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 206. ASEAN RADIOIMMUNOASSAYS MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 207. ASEAN RADIOIMMUNOASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 208. ASEAN RADIOIMMUNOASSAYS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 209. ASEAN RADIOIMMUNOASSAYS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 210. ASEAN RADIOIMMUNOASSAYS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 211. GCC RADIOIMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 212. GCC RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 213. GCC RADIOIMMUNOASSAYS MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 214. GCC RADIOIMMUNOASSAYS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 215. GCC RADIOIMMUNOASSAYS MARKET SIZE, BY ANTIBODY, 2018-2032 (USD MILLION)
TABLE 216. GCC RADIOIMMUNOASSAYS MARKET SIZE, BY ISOTOPE, 2018-2032 (USD MILLION)
TABLE 217. GCC RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 218. GCC RADIOIMMUNOASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 219. GCC RADIOIMMUNOASSAYS MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 220. GCC RADIOIMMUNOASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 221. GCC RADIOIMMUNOASSAYS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 222. GCC RADIOIMMUNOASSAYS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 223. GCC RADIOIMMUNOASSAYS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 224. EUROPEAN UNION RADIOIMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 225. EUROPEAN UNION RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 226. EUROPEAN UNION RADIOIMMUNOASSAYS MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 227. EUROPEAN UNION RADIOIMMUNOASSAYS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 228. EUROPEAN UNION RADIOIMMUNOASSAYS MARKET SIZE, BY ANTIBODY, 2018-2032 (USD MILLION)
TABLE 229. EUROPEAN UNION RADIOIMMUNOASSAYS MARKET SIZE, BY ISOTOPE, 2018-2032 (USD MILLION)
TABLE 230. EUROPEAN UNION RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 231. EUROPEAN UNION RADIOIMMUNOASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 232. EUROPEAN UNION RADIOIMMUNOASSAYS MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 233. EUROPEAN UNION RADIOIMMUNOASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 234. EUROPEAN UNION RADIOIMMUNOASSAYS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 235. EUROPEAN UNION RADIOIMMUNOASSAYS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 236. EUROPEAN UNION RADIOIMMUNOASSAYS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 237. BRICS RADIOIMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 238. BRICS RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 239. BRICS RADIOIMMUNOASSAYS MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 240. BRICS RADIOIMMUNOASSAYS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 241. BRICS RADIOIMMUNOASSAYS MARKET SIZE, BY ANTIBODY, 2018-2032 (USD MILLION)
TABLE 242. BRICS RADIOIMMUNOASSAYS MARKET SIZE, BY ISOTOPE, 2018-2032 (USD MILLION)
TABLE 243. BRICS RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 244. BRICS RADIOIMMUNOASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 245. BRICS RADIOIMMUNOASSAYS MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 246. BRICS RADIOIMMUNOASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 247. BRICS RADIOIMMUNOASSAYS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 248. BRICS RADIOIMMUNOASSAYS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 249. BRICS RADIOIMMUNOASSAYS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 250. G7 RADIOIMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 251. G7 RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 252. G7 RADIOIMMUNOASSAYS MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 253. G7 RADIOIMMUNOASSAYS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 254. G7 RADIOIMMUNOASSAYS MARKET SIZE, BY ANTIBODY, 2018-2032 (USD MILLION)
TABLE 255. G7 RADIOIMMUNOASSAYS MARKET SIZE, BY ISOTOPE, 2018-2032 (USD MILLION)
TABLE 256. G7 RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 257. G7 RADIOIMMUNOASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 258. G7 RADIOIMMUNOASSAYS MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 259. G7 RADIOIMMUNOASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 260. G7 RADIOIMMUNOASSAYS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 261. G7 RADIOIMMUNOASSAYS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 262. G7 RADIOIMMUNOASSAYS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 263. NATO RADIOIMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 264. NATO RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 265. NATO RADIOIMMUNOASSAYS MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 266. NATO RADIOIMMUNOASSAYS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 267. NATO RADIOIMMUNOASSAYS MARKET SIZE, BY ANTIBODY, 2018-2032 (USD MILLION)
TABLE 268. NATO RADIOIMMUNOASSAYS MARKET SIZE, BY ISOTOPE, 2018-2032 (USD MILLION)
TABLE 269. NATO RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 270. NATO RADIOIMMUNOASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 271. NATO RADIOIMMUNOASSAYS MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 272. NATO RADIOIMMUNOASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 273. NATO RADIOIMMUNOASSAYS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 274. NATO RADIOIMMUNOASSAYS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 275. NATO RADIOIMMUNOASSAYS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 276. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 277. UNITED STATES RADIOIMMUNOASSAYS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 278. UNITED STATES RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 279. UNITED STATES RADIOIMMUNOASSAYS MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 280. UNITED STATES RADIOIMMUNOASSAYS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 281. UNITED STATES RADIOIMMUNOASSAYS MARKET SIZE, BY ANTIBODY, 2018-2032 (USD MILLION)
TABLE 282. UNITED STATES RADIOIMMUNOASSAYS MARKET SIZE, BY ISOTOPE, 2018-2032 (USD MILLION)
TABLE 283. UNITED STATES RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 284. UNITED STATES RADIOIMMUNOASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 285. UNITED STATES RADIOIMMUNOASSAYS MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 286. UNITED STATES RADIOIMMUNOASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 287. UNITED STATES RADIOIMMUNOASSAYS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 288. UNITED STATES RADIOIMMUNOASSAYS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 289. UNITED STATES RADIOIMMUNOASSAYS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 290. CHINA RADIOIMMUNOASSAYS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 291. CHINA RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 292. CHINA RADIOIMMUNOASSAYS MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 293. CHINA RADIOIMMUNOASSAYS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 294. CHINA RADIOIMMUNOASSAYS MARKET SIZE, BY ANTIBODY, 2018-2032 (USD MILLION)
TABLE 295. CHINA RADIOIMMUNOASSAYS MARKET SIZE, BY ISOTOPE, 2018-2032 (USD MILLION)
TABLE 296. CHINA RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 297. CHINA RADIOIMMUNOASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 298. CHINA RADIOIMMUNOASSAYS MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 299. CHINA RADIOIMMUNOASSAYS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 300. CHINA RADIOIMMUNOASSAYS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 301. CHINA RADIOIMMUNOASSAYS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 302. CHINA RADIOIMMUNOASSAYS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Radioimmunoassays market report include:
  • Abbott Laboratories
  • Abcam plc
  • ALPCO Diagnostics, Inc.
  • Beckman Coulter, Inc.
  • Bio-Rad Laboratories, Inc.
  • BioCheck, Inc.
  • bioMérieux SA
  • Cisbio Bioassays SAS
  • Demeditec Diagnostics GmbH
  • DiaSorin S.p.A.
  • Euroimmun Medizinische Labordiagnostika AG
  • Fujirebio Holdings, Inc.
  • Institute of Isotopes Co., Ltd.
  • Medipan GmbH
  • MilliporeSigma
  • NovoLytiX GmbH
  • PerkinElmer, Inc.
  • Randox Laboratories Ltd.
  • Roche Diagnostics International AG
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • Tosoh Bioscience, Inc.

Table Information

Report AttributeDetails
No. of Pages184
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 520.05 Million
Forecasted Market Value ( USD ) by 2032 $ 675.38 Million
Compound Annual Growth Rate4.6%
Regions CoveredGlobal
No. of Companies Mentioned23

Related Topics

Related Reports

Radioimmunoassay Market Size, Share & Trends Analysis Report by Product (Analyzers, Reagents & Kits), Application (Research, Clinical Diagnostics), End Use (Hospitals, Laboratory), Region, with Growth Forecasts, 2025-2030 - Product Image

Radioimmunoassay Market Size, Share & Trends Analysis Report by Product (Analyzers, Reagents & Kits), Application (Research, Clinical Diagnostics), End Use (Hospitals, Laboratory), Region, with Growth Forecasts, 2025-2030

  • Report
  • 320 Pages
  • Global
From
Radioimmunoassay Market Outlook 2026-2034: Market Share, and Growth Analysis - Product Image

Radioimmunoassay Market Outlook 2026-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Radioimmunoassay Market - Diagnostic Applications & Forecast 2025-2033 - Product Image

Radioimmunoassay Market - Diagnostic Applications & Forecast 2025-2033

  • Report
  • 200 Pages
  • Global
From
Radioimmunoassays - Global Strategic Business Report - Product Image

Radioimmunoassays - Global Strategic Business Report

  • Report
  • 193 Pages
  • Global
From
Immunoassay Analyzers Market Size, Share & Trends Analysis Report By Product (Chemiluminescence Immunoassays, Fluorescence Immunoassay, Radioimmunoassay), By Application (Oncology, Cardiology), By End-use, By Region And Segment Forecasts, 2025 - 2030 - Product Image

Immunoassay Analyzers Market Size, Share & Trends Analysis Report By Product (Chemiluminescence Immunoassays, Fluorescence Immunoassay, Radioimmunoassay), By Application (Oncology, Cardiology), By End-use, By Region And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From

About the Radioimmunoassay Market

Radioimmunoassay (RIA) is a laboratory technique used to measure the concentration of antigens, such as hormones, in a sample. In the context of oncology drugs, RIA is used to measure the concentration of tumor markers in the blood, which can help diagnose and monitor cancer. RIA can also be used to measure the concentration of therapeutic drugs in the blood, which can help determine the effectiveness of a drug and its dosage. RIA is a highly sensitive and specific technique, and is used in many clinical laboratories. It is also used in research laboratories to study the pharmacokinetics of drugs, and to develop new drugs. In the oncology drug market, RIA is used to measure the concentration of therapeutic drugs in the blood, and to monitor the effectiveness of the drug. It is also used to measure the concentration of tumor markers in the blood, which can help diagnose and monitor cancer. Some companies in the RIA market for oncology drugs include Abbott Laboratories, Beckman Coulter, Siemens Healthcare, and Roche Diagnostics. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.